The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury
Abstract
Object. The authors prospectively studied the efficacy of tirilazad mesylate, a novel aminosteroid, in humans with head injuries. Methods. A cohort of 1120 head-injured patients received at least one dose of study medication (tirilazad or placebo). Eighty-five percent (957) of the patients had suffered a severe head injury (Glasgow Coma Scale [GCS] score 4–8) and 15% (163) had sustained a moderate head injury (GCS score 9–12). Six-month outcomes for the tirilazad- and placebo-treated groups for the Glasgow Outcome Scale categories of both good recovery and death showed no significant difference (good recovery in the tirilazad-treated group was 39% compared with the placebo group in which it was 42% [p = 0.461]; death in the tirilazad-treated group occurred in 26% of patients compared with the placebo group, in which it occurred in 25% [p = 0.750]). Subgroup analysis suggested that tirilazad mesylate may be effective in reducing mortality rates in males suffering from severe head injury with accompanying traumatic subarachnoid hemorrhage (death in the tirilazad-treated group occurred in 34% of patients; in the placebo group it occurred in 43% [p = 0.026]). No significant differences in frequency or types of serious adverse events were shown between the treatment and placebo groups. Conclusions. Striking problems with imbalance concerning basic prognostic variables were observed in spite of the large population studied. These imbalances concerned pretreatment hypotension, pretreatment hypoxia, and the incidence of epidural hematomas. In future trials of pharmacological therapy for severe head injury, serious consideration must be given to alternative randomization strategies. Given the heterogeneous nature of head injury and the identification of populations that do relatively well with standard therapy, target populations with a higher risk for mortality and morbidity may be more suitable for clinical trials of such agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
THE ROLE OF SECONDARY BRAIN INJURY IN DETERMINING OUTCOME FROM SEVERE HEAD INJURY
Chesnut, R. M., Marshall, L. F., Klauber, M. R., Blunt, B. A., Baldwin, N., Eisenberg, H. M., Jane, J. A., Marmarou, A., & Foulkes, M. A. (1993) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199302000-00006 · Cited by 2,189
Self-citationA new classification of head injury based on computerized tomography
Marshall, L. F., Marshall, S. B., Klauber, M. R., Clark, M. V. B., Eisenberg, H. M., Jane, J. A., Luerssen, T. G., Marmarou, A., & Foulkes, M. A. (1991) · Journal of Neurosurgery · doi:10.3171/sup.1991.75.1s.0s14 · Cited by 1,326
Self-citationCentral nervous system trauma and stroke
Hall, E. D., & Braughler, J. M. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90057-9 · Cited by 586
Kassell, N. F., Haley, E. C., Apperson-Hansen, C., Alves, W. M., & _, _. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.84.2.0221 · Cited by 394
Effects of the 21-aminosteroid U74006F on experimental head injury in mice
Hall, E. D., Yonkers, P. A., McCall, J. M., & Braughler, J. M. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.3.0456 · Cited by 295
Cytokines and Metabolic Dysfunction After Severe Head Injury
OTT, L., McCLAIN, C. J., GILLESPIE, M., & YOUNG, B. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.447 · Cited by 266
Hall, E. D., & Braughler, J. M. (1993) · PubMed · Cited by 226
Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury.
Hall, E. D., Yonkers, P. A., Andrus, P. K., Cox, J. W., & Anderson, D. K. (1992) · PubMed · Cited by 197
MCINTOSH, T. K., VINK, R., SOARES, H., HAYES, R., & SIMON, R. (1989) · Journal of Neurotrauma · doi:10.1089/neu.1989.6.247 · Cited by 183
McIntosh, T. K., Thomas, M. J., SMITH, D., & Banbury, M. K. (1992) · Journal of Neurotrauma · doi:10.1089/neu.1992.9.33 · Cited by 94
Nimodipine in traumatic subarachnoid haemorrhage: A re-analysis of the HIT I and HIT II trials
Murray, G. D., Teasdale, G. M., & Schmilz, H. (1996) · Acta Neurochirurgica · doi:10.1007/bf01809745 · Cited by 60
Young, B. (1996) · JAMA · doi:10.1001/jama.276.7.538 · Cited by 35
Molecular and Cellular Approaches to the Treatment of Neurological Disease
Waxman, E. A. (1994) · American Journal of Therapeutics · doi:10.1097/00045391-199408000-00013 · Cited by 33
Cited by
Moderate and severe traumatic brain injury in adults
Maas, A. I., Stocchetti, N., & Bullock, R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70164-9 · Cited by 2,123
Self-citationThe far-reaching scope of neuroinflammation after traumatic brain injury
Simon, D. W., McGeachy, M. J., Bayır, H., Clark, R. S. B., Loane, D. J., & Kochanek, P. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.13 · Cited by 1,190
Glutamate receptors, neurotoxicity and neurodegeneration
Lau, A., & Tymianski, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0809-1 · Cited by 1,185
Maas, A. I. R., Hukkelhoven, C. W. P. M., Marshall, L. F., & Steyerberg, E. W. (2005) · Neurosurgery · doi:10.1227/01.neu.0000186013.63046.6b · Cited by 939
Self-citationClinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913
Self-citation
Metadata
- Authors
- Marshall, L. F., Maas, A. I. R., Marshall, S. B., Bricolo, A., Fearnside, M., Iannotti, F., Klauber, M. R., Lagarrigue, J., Lobato, R., Persson, L., Pickard, J. D., Piek, J., Servadei, F., Wellis, G. N., Morris, G. F., Means, E. D., & Musch, B.
- Venue
- Journal of Neurosurgery
- Published
- 1998-10
- Volume
- 89
- Issue
- 4
- Pages
- 519-525
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2104730217
- Cited by
- 336
- References
- 14
- FWCI
- 17.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.